2025-02-19 IDOPRESS

SOUTHFIELD,Mich.,Feb. 18,2025 -- Lear Corporation (NYSE: LEA),a global automotive technology leader in Seating and E-Systems,today announced it has purchased StoneShield Engineering,a privately held system integrator based in Castelo Branco,Portugal.
Founded in 2017,StoneShield Engineering specializes in the design and development of automation technology for the wire harness industry. Key areas of expertise include robotics,automated taping applications and high voltage harness assembly.
"By utilizing StoneShield's expertise,we will accelerate the automation of our production processes throughout our E-Systems business," said President and CEO Ray Scott. "We will also develop new advanced technologies for our wire harness production,further improving our efficiency and operational excellence."
This acquisition is a component of Lear's IDEA (Innovative,Digital,Engineered and Automated) by Lear strategy,which focuses on leveraging technology and innovation to drive operational excellence. It is part of the successful integration of previous acquisitions,including WIP Industrial Automation,ASI Automation,Thagora Technology SRL,and InTouch Automation.
Collectively,these strategic acquisitions equip Lear with a robust portfolio of automation solutions and expertise,positioning the company as a leader in the use of next-generation automotive manufacturing technologies.
About Lear Corporation
Lear,enables superior in-vehicle experiences for consumers around the world. Lear's diverse team of talented employees in 38 countries is driven by a commitment to innovation,operational excellence,and sustainability. Lear is Making every drive better™ by providing the technology for safer,smarter,and more comfortable journeys. Lear,headquartered in Southfield,Michigan,serves every major automaker in the world and ranks 174 on the Fortune 500. Further information about Lear is available at lear.com.
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map